- Home
- RBOT vs VIGL Comparison
RBOT vs VIGL Comparison
Compare RBOT & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBOT
- VIGL
- Stock Information
- Founded
- RBOT 2014
- VIGL 2020
- Country
- RBOT United States
- VIGL United States
- Employees
- RBOT N/A
- VIGL N/A
- Industry
- RBOT Medical Specialities
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- RBOT Health Care
- VIGL Health Care
- Exchange
- RBOT Nasdaq
- VIGL Nasdaq
- Market Cap
- RBOT 45.8M
- VIGL 134.9M
- IPO Year
- RBOT N/A
- VIGL 2022
- Fundamental
- Price
- RBOT $9.30
- VIGL $8.07
- Analyst Decision
- RBOT Hold
- VIGL Buy
- Analyst Count
- RBOT 2
- VIGL 7
- Target Price
- RBOT $9.25
- VIGL $8.00
- AVG Volume (30 Days)
- RBOT 15.6K
- VIGL 798.1K
- Earning Date
- RBOT 08-11-2025
- VIGL 08-12-2025
- Dividend Yield
- RBOT N/A
- VIGL N/A
- EPS Growth
- RBOT N/A
- VIGL N/A
- EPS
- RBOT N/A
- VIGL N/A
- Revenue
- RBOT N/A
- VIGL N/A
- Revenue This Year
- RBOT N/A
- VIGL N/A
- Revenue Next Year
- RBOT N/A
- VIGL N/A
- P/E Ratio
- RBOT N/A
- VIGL N/A
- Revenue Growth
- RBOT N/A
- VIGL N/A
- 52 Week Low
- RBOT $4.27
- VIGL $1.31
- 52 Week High
- RBOT $19.00
- VIGL $8.11
- Technical
- Relative Strength Index (RSI)
- RBOT 74.72
- VIGL 89.08
- Support Level
- RBOT $7.21
- VIGL $8.03
- Resistance Level
- RBOT $8.30
- VIGL $8.05
- Average True Range (ATR)
- RBOT 0.52
- VIGL 0.03
- MACD
- RBOT 0.20
- VIGL -0.12
- Stochastic Oscillator
- RBOT 100.00
- VIGL 86.73
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.